Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Prosthodont Restor Dent ; 28(3): 113-120, 2020 Aug 31.
Article in English | MEDLINE | ID: mdl-32363813

ABSTRACT

To evaluate fracture resistance of occlusal veneers made of glass-ceramic and zirconia with and without fatigue. Occlusal overlays (N=80; n=10 per group) were milled out of CAD/CAM materials, namely: a)LD:Lithium disilicate glass ceramic, b)LDS:Lithium-disilicate- strengthened aluminosilicate glass ceramic, c)ZLT:Zirconium dioxide ceramic and d)ZMT:Zirconium dioxide ceramic. The overlays were cemented on polymeric duplicates, randomly distributed to aging or non-aging conditions and loaded until fracture. Ultimate catastrophic failure strength(Fmax) and Initial crack formation load(Finitial) values were analysed using two-way ANOVA. For Finitial, material type and aging and their interaction resulted in significant values (p =⟨0.001). Finitial mean±SD values ranged from ZMTa (593 N ±205 N) to LDSb (118 N ±42 N). As for Fmax, the material type significantly affected the outcome (p⟨0.001), while aging type did not show an influence (p=0.795). The non-aged Fmax specimens values presented were: LDSa (877 N ±253 N)⟨LDa (2029 N ±412 N)⟨ZLTa (2049 N ±379 N)⟨ZMTa (2144 N ±333 N), LDSa being significantly lower (p⟨0.001). The aged Fmax values were: LDSb (1313 N ±599 N)⟨ ZLTb (1715 N ±453 N)⟨ZMTb (2018 N ±300 N)⟨LDb (2134 N ±289 N). LDS yielded significantly lower Fmax values without and non-significant less favourable results with aging. The mechanical properties following aging and lack of additional firing makes LDS an interesting restorative material for clinical application.


Subject(s)
Dental Porcelain , Dental Veneers , Ceramics , Computer-Aided Design , Dental Stress Analysis , Materials Testing , Zirconium
2.
Leukemia ; 30(10): 1993-2001, 2016 10.
Article in English | MEDLINE | ID: mdl-27118408

ABSTRACT

Mutations in the DYNAMIN2 (DNM2) gene are frequently detected in human acute T-cell lymphoblastic leukemia (T-ALL), although the mechanisms linking these mutations to disease pathogenesis remain unknown. Using an ENU-based forward genetic screen for mice with erythroid phenotypes, we identified a heterozygous mouse line carrying a mutation in the GTPase domain of Dnm2 (Dnm2V265G) that induced a microcytic anemia. In vitro assays using the V265G mutant demonstrated loss of GTPase activity and impaired endocytosis that was comparable to other DNM2 mutants identified in human T-ALL. To determine the effects of DNM2 mutations in T-ALL, we bred the Dnm2V265G mice with the Lmo2 transgenic mouse model of T-ALL. Heterozygous Dnm2 mutants lacking the Lmo2 transgene displayed normal T-cell development, and did not develop T-ALL. In contrast, compound heterozygotes displayed an accelerated onset of T-ALL compared with mice carrying the Lmo2 oncogene alone. The leukemias from these mice exhibited a more immature immunophenotype and an expansion in leukemic stem cell numbers. Mechanistically, the Dnm2 mutation impaired clathrin-mediated endocytosis of the interleukin (IL)-7 receptor resulting in increased receptor density on the surface of leukemic stem cells. These findings suggest that DNM2 mutations cooperate with T-cell oncogenes by enhancing IL-7 signalling.


Subject(s)
Dynamin II/genetics , Interleukin-7/metabolism , Leukemia, T-Cell/etiology , Mutation , Adaptor Proteins, Signal Transducing/genetics , Animals , Endocytosis/genetics , GTP Phosphohydrolases/metabolism , Humans , LIM Domain Proteins/genetics , Leukemia, T-Cell/genetics , Leukemia, T-Cell/metabolism , Mice , Oncogenes , Signal Transduction
3.
Placenta ; 34(11): 1014-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24074901

ABSTRACT

INTRODUCTION: Ectopic pregnancy is unique to humans and a leading cause of maternal morbidity and mortality. The etiology remains unknown however factors regulating embryo implantation likely contribute. Leukemia inhibitory factor (LIF) has roles in extravillous trophoblast adhesion and invasion and is present in ectopic implantation sites. We hypothesised that LIF facilitates blastocyst adhesion/invasion in the Fallopian tube, contributing to ectopic pregnancy. METHODS: We immunolocalised LIF receptor (R) in tubal ectopic pregnancy (N = 5). We used an oviduct cell line (OE-E6/E7) to model Fallopian tube epithelial cells and a trophoblast spheroid co-culture model (HTR-8/SVneo cell line formed spheroids) to model blastocyst attachment to the Fallopian tube. We examined LIF signaling pathways in OE-E6/E7 cells by Western blot. The effect of LIF and LIF inhibition (using a novel LIF inhibitor, PEGLA) on first-trimester placental outgrowth was determined. RESULTS: LIFR localised to villous and extravillous trophoblast and Fallopian tube epithelium in ectopic pregnancy. LIF activated STAT3 but not the ERK pathway in OE-E6/E7 cells. LIF stimulated HTR-8/SVneo spheroid adhesion to OE-E6/E7 cells which was significantly reduced after PEGLA treatment. LIF promoted placental explants outgrowth, while co-treatment with PEGLA blocked outgrowth. DISCUSSION: Our data suggests LIF facilitates the development of ectopic pregnancy by stimulating blastocyst adhesion and trophoblast outgrowth from placental explants. Ectopic pregnancy is usually diagnosed after 6 weeks of pregnancy, therefore PEGLA may be useful in targeting trophoblast growth/invasion. CONCLUSION: LIF may contribute to the development of ectopic pregnancies and that pharmacologically targeting LIF-mediated trophoblast outgrowth may be useful as a treatment for ectopic pregnancy.


Subject(s)
Blastocyst/metabolism , Fallopian Tubes/metabolism , Leukemia Inhibitory Factor Receptor alpha Subunit/metabolism , Leukemia Inhibitory Factor/metabolism , Placenta/metabolism , Pregnancy, Tubal/metabolism , Signal Transduction , Adolescent , Adult , Blastocyst/drug effects , Blastocyst/pathology , Cell Adhesion/drug effects , Cell Line , Cell Proliferation/drug effects , Coculture Techniques , Embryo Implantation/drug effects , Epithelium/drug effects , Epithelium/metabolism , Epithelium/pathology , Fallopian Tubes/drug effects , Fallopian Tubes/pathology , Fallopian Tubes/surgery , Female , Humans , Leukemia Inhibitory Factor/antagonists & inhibitors , Leukemia Inhibitory Factor/genetics , Leukemia Inhibitory Factor/pharmacology , Leukemia Inhibitory Factor Receptor alpha Subunit/agonists , Leukemia Inhibitory Factor Receptor alpha Subunit/antagonists & inhibitors , Leukemia Inhibitory Factor Receptor alpha Subunit/genetics , Middle Aged , Placenta/drug effects , Placenta/pathology , Polyethylene Glycols/pharmacology , Pregnancy , Pregnancy, Tubal/pathology , Pregnancy, Tubal/surgery , STAT3 Transcription Factor/agonists , STAT3 Transcription Factor/antagonists & inhibitors , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Spheroids, Cellular , Tissue Culture Techniques , Young Adult
4.
Placenta ; 31(10): 839-47, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20716463

ABSTRACT

The family of secreted Wingless ligands plays major roles in embryonic development, stem cell maintenance, differentiation and tissue homeostasis. Accumulating evidence suggests that the canonical Wnt pathway involving nuclear recruitment of ß-catenin and activation of Wnt-dependent transcription factors is also critically involved in development and differentiation of the diverse reproductive tissues. Here, we summarise our present knowledge about expression, regulation and function of Wnt ligands and their frizzled receptors in murine and human endometrial and placental cell types. In mice, Wnt signalling promotes early trophoblast lineage development, blastocyst activation, implantation and chorion-allantois fusion. Moreover, different Wnt ligands play essential roles in the development of the murine uterine tract, in cycling endometrial cells and during decidualisation. In humans, estrogen-dependent endometrial cell proliferation, decidualisation, trophoblast attachment and invasion were shown to be controlled by the particular signalling pathway. Failures in Wnt signalling are associated with infertility, endometriosis, endometrial cancer and gestational diseases such as complete mole placentae and choriocarcinomas. However, our present knowledge is still scarce due to the complexity of the Wnt network involving numerous ligands, receptors and non-canonical pathways. Hence, much remains to be learned about the role of different Wnt signalling cascades in reproductive cell types and their changes under pathological conditions.


Subject(s)
Endometrium/physiology , Frizzled Receptors/physiology , Placenta/physiology , Reproduction/physiology , Signal Transduction/physiology , Wnt Proteins/physiology , Animals , Cell Differentiation/physiology , Decidua/physiology , Embryo Implantation/physiology , Endometrium/cytology , Female , Humans , Mice , Placenta/cytology , Pregnancy
5.
Placenta ; 30(3): 284-91, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19155066

ABSTRACT

MMP-3 has been detected in human placenta and reduced expression of the enzyme was observed in invasive trophoblasts of patients with severe preeclampsia. However, detailed expression pattern, regulation and biological properties of the placental protease have not been elucidated so far. RT-PCR analyses, Western blotting and enzyme activity assays revealed that pro- and active form of MMP-3 were predominantly expressed in purified first trimester villous trophoblasts, in invasive cytotrophoblasts of differentiating explant cultures and in trophoblastic SGHPL-4 cells. Accordingly, immunofluorescene of first trimester placental tissues detected MMP-3 mainly in villous and extravillous cytotrophoblasts. IL-1beta, an inducer of MMP-3 in decidual cells, increased secretion and activity of the protease in trophoblast supernatants in a dose- and time-dependent manner. IL-1beta-stimulated production of the enzyme was suppressed in the presence of inhibitors of MAPK and AKT signalling. Similar to recombinant MMP-3, MMP-3 in supernatants of IL-1beta-stimulated decidual stromal or SGHPL-4 cells degraded IGFBP-1 in vitro resulting in the appearance of cleavage products at approximately 25, 22, 17, 14 and 11kD. However, cleavage assays using recombinant MMP-2 suggested that the gelatinase may contribute to IGFBP-1 degradation in trophoblast supernatants. Despite its effects on MMP-3 expression IL-1beta failed to significantly alter invasion of SGHPL-4 cells through Matrigel-coated transwells. In conclusion, the data suggest that invasive trophoblast cell models secrete bioactive MMP-3. Inducible expression of the protease involves MAPK and AKT signalling. In addition to the decidua, MMP-3 of trophoblasts may contribute to the regulation of the IGF system by degrading IGFBP-1.


Subject(s)
Insulin-Like Growth Factor Binding Protein 1/metabolism , Matrix Metalloproteinase 3/metabolism , Placenta/metabolism , Trophoblasts/metabolism , Cell Line , Female , Fibroblasts/metabolism , Humans , Interleukin-1beta/metabolism , MAP Kinase Signaling System , Pregnancy , Proto-Oncogene Proteins c-akt/metabolism
6.
Placenta ; 28 Suppl A: S97-102, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17198728

ABSTRACT

Canonical Wingless (Wnt) signalling provoked by exogenous and endogenous Wnt ligands was recently shown to play a crucial role in the invasive differentiation of human trophoblasts. To gain insights into the expression pattern of the developmental regulators, we analysed all human Wnt ligands and their frizzled (FZD) receptors in the human placenta and different trophoblast model systems using semi-quantitative PCR. Fourteen out of 19 Wnt ligands and 8 out of 10 FZD receptors were detectable in placental tissues, however, expression patterns varied with gestational age and between different trophoblast subtypes suggesting cell-specific functions. Besides Wnt ligands acting through the canonical pathway, non-canonical ligands such as Wnt-5a, which may also activate alternative Wnt signalling pathways or inhibit canonical Wnt signalling, could be identified. Western blot analyses revealed secretion of Wnt-5a from primary trophoblast cultures and trophoblastic cell lines. To evaluate the potential role of Wnt-5a, SGHPL-5 trophoblast cells were transfected with luciferase reporter plasmids harbouring eight T-cell factor (TCF) DNA-recognition sequences which are exclusively activated through the canonical Wnt signalling pathway. Luciferase assays revealed that Wnt-3a-induced reporter activity was repressed by recombinant Wnt-5a indicating an antagonistic role in trophoblasts. The data suggest that a complex network of Wnt ligands and FZD receptors may regulate developmental processes of the human placenta.


Subject(s)
Frizzled Receptors/metabolism , Placenta/metabolism , Trophoblasts/metabolism , Wnt Proteins/metabolism , Cells, Cultured , Female , Frizzled Receptors/genetics , Genes, Reporter , Humans , Ligands , Plasmids/genetics , Pregnancy , RNA, Messenger/analysis , RNA, Messenger/metabolism , TCF Transcription Factors/metabolism , Transfection , Wnt Proteins/genetics
7.
Mol Hum Reprod ; 12(10): 601-9, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16896069

ABSTRACT

Growth factors expressed at the fetal-maternal interface modulate hormone expression of placental trophoblasts. The aim of this study was to investigate the effects of different cytokines on hCG subunit mRNA expression in differentiating villous cytotrophoblasts. Quantitative real-time PCR revealed a 1.8- and 6.9-fold increase of hCG-alpha and hCG-beta mRNA levels, respectively, between 36 and 60 h of term trophoblast syncytialization. Compared with controls, neither interleukin (IL)-1beta, IL-2, IL-4, IL-6, IL-10, IL-13 and IL-15 nor tumour necrosis factor (TNF)-alpha significantly altered hCG-alpha mRNA expression. Similarly, the ILs did not affect hCG-beta transcript levels. In contrast, TNF-alpha suppressed hCG-beta mRNA 3.8- and 1.8-fold at 36 and 60 h of term trophoblast differentiation. Accordingly, hCG secretion was impaired by TNF-alpha but not by the different ILs. Moreover, TNF-alpha reduced luciferase expression of reporter plasmids harbouring the proximal hCG-beta5 promoter to 35 and 77%, respectively, in primary term trophoblasts and trophoblastic SHGPL-5 cells. In addition, counting of nuclei in syncytialized, desmoplakin-negative areas revealed a 1.9-fold reduction of term trophoblast fusion in the presence of TNF-alpha. Similarly, floating explant cultures prepared from first trimester-denuded villi recovered the syncytium 2.8-fold less efficiently during 72 h of cytokine treatment. Concomitantly, TNF-alpha impaired induction of endogenous and secreted hCG-beta protein levels in these cultures. The data suggest that TNF-alpha decreases hCG-beta mRNA and protein expression by reducing gene transcription and trophoblast cell fusion. Suppression of these processes by TNF-alpha could partly explain the adverse effects of the cytokine on placental function and pregnancy outcome.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human/metabolism , Chorionic Villi/metabolism , Trophoblasts/metabolism , Tumor Necrosis Factor-alpha/metabolism , Cell Differentiation , Cell Fusion , Cell Line , Chorionic Gonadotropin, beta Subunit, Human/genetics , Chorionic Villi/drug effects , Down-Regulation , Female , Glycoprotein Hormones, alpha Subunit/metabolism , Humans , Pregnancy , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism , Transfection , Trophoblasts/drug effects
8.
Nature ; 438(7067): 479-82, 2005 Nov 24.
Article in English | MEDLINE | ID: mdl-16306988

ABSTRACT

Picosecond and femtosecond spectroscopy allow the detailed study of carrier dynamics in nanostructured materials. In such experiments, a laser pulse normally excites several nanostructures at once. However, spectroscopic information may also be acquired using pulses from an electron beam in a modern electron microscope, exploiting a phenomenon called cathodoluminescence. This approach offers several advantages. The multimode imaging capabilities of the electron microscope enable the correlation of optical properties (via cathodoluminescence) with surface morphology (secondary electron mode) at the nanometre scale. The broad energy range of the electrons can excite wide-bandgap materials, such as diamond- or gallium-nitride-based structures that are not easily excited by conventional optical means. But perhaps most intriguingly, the small beam can probe a single selected nanostructure. Here we apply an original time-resolved cathodoluminescence set-up to describe carrier dynamics within single gallium-arsenide-based pyramidal nanostructures with a time resolution of 10 picoseconds and a spatial resolution of 50 nanometres. The behaviour of such charge carriers could be useful for evaluating elementary components in quantum computers, optical quantum gates or single photon sources for quantum cryptography.

SELECTION OF CITATIONS
SEARCH DETAIL
...